PEI (Paul-Ehrlich Institute) selected for WHO blood/IVDs group:
This article was originally published in Clinica
Germany's federal office for sera and immunology, the Paul-Ehrlich Institute (PEI), has been selected to join the WHO's co-operation centre for quality assurance in blood products and in vitro diagnostics. The Langen-based unit, which took over responsibility for these area from the former BGA in 1994, will support the WHO in lifting standards "to a level that we have long enjoyed in Germany and Europe", said state secretary at the health ministry Dr Klaus Theo Schroder. Head of the PEI's haematology and transfusion medicine division Professor Rainer Seitz will represent the German institute at the co-operation centre for an initial four-year term.
You may also be interested in...
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.